Perspectives Articles

·        Wilson MR, Satapathy S, Jeong S, Fini  ME. Clusterin, other extracellular chaperones, and eye disease. Progress in retinal and eye research. 2022;89:101032

·        Fini ME, Jeong S, Wilson MR. Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye. International journal of molecular sciences. 2020;22(1).

·        Fini ME, Bauskar A, Jeong S, Wilson MR. Clusterin in the eye: An old dog with new tricks at the ocular surface. Experimental eye research. 2016;147:57-71.

·        Dabbs RA, Wyatt AR, Yerbury JJ, Ecroyd H, Wilson MR. Extracellular chaperones. Top Curr Chem. 2013;328:241-68.

·        Wyatt AR, Yerbury JJ, Ecroyd H, Wilson MR. Extracellular chaperones and proteostasis. Annual review of biochemistry. 2013;82:295-322.

Original Research Articles

·        Chintala SK, Pan J, Satapathy S, Condruti R, Hao Z, Liu PW, O’Conner CF, Barr JT, Wilson MR, Jeong S, Fini ME. Recombinant Human Clusterin Seals Damage to the Ocular Surface Barrier in a Mouse Model of Ophthalmic Preservative-Induced Epitheliopathy. International journal of molecular sciences. 2023;24(2).

·        Satapathy S, Dabbs RA, Wilson MR. Rapid high-yield expression and purification of fully post-translationally modified recombinant clusterin and mutants. Scientific reports. 2020;10(1):14243.

·        Yu V, Bhattacharya D, Webster A, Bauskar A, Flowers C, Heur M, Chintala SK, Itakura T, Wilson MR, Barr JT, Jeong S, Wang M, Fini ME. Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results. The ocular surface. 2018.

·        Cunin P, Beauvillain C, Miot C, Augusto JF, Preisser L, Blanchard S, Pignon P, Scotet M, Garo E, Fremaux I, Chevallier A, Subra J-F, Blanco P, Wilson ME, Jeannin P, Delneste Y. Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses. Cell Death Dis. 2016;7:e2215.

·        Bauskar A, Mack WJ, Mauris J, Argueso P, Heur M, Nagle BA, Kolar GE, Gleave ME, Nakamura T, Kinoshita S, Moradian-Oldak J, Panjwani N,  Wilson MR, Pflugfelder S, Fini ME, Jeong S. Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye. PloS one. 2015;10(9):e0138958.

·        Jeong S, Ledee DR, Gordon GM, Itakura T, Patel N, Fini ME et al. Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation. The American journal of pathology. 2012;180(5):2028-39.

·        Pflugfelder SC, Farley W, Luo L, Chen LZ, de Paiva CS, Olmos LC ,Li D-Q, Fini ME. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. The American journal of pathology. 2005;166(1):61-71.

·        Nakamura T, Nishida K, Dota A, Kinoshita S. Changes in conjunctival clusterin expression in severe ocular surface disease. Investigative ophthalmology & visual science. 2002;43(6):1702-7.

·        Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR. Clusterin has chaperone-like activity similar to that of small heat shock proteins. The Journal of biological chemistry. 1999;274(11):6875-81.

·        Nishida K, Kawasaki S, Kinoshita S. Clusterin may be essential for maintaining ocular surface epithelium as a non-keratinizing epithelium. Advances in experimental medicine and biology. 1998;438:629-35.

·        Nishida K, Kawasaki S, Adachi W, Kinoshita S. Apolipoprotein J expression in human ocular surface epithelium. Investigative ophthalmology & visual science. 1996;37(11):2285-92.

·        Nishida K, Adachi W, Shimizu-Matsumoto A, Kinoshita S, Mizuno K, Matsubara K, et al. A gene expression profile of human corneal epithelium and the isolation of human keratin 12 cDNA. Investigative ophthalmology & visual science. 1996;37(9):1800-9.